More Adheris Health Limited news
Adheris Health LimitedASX: AHE

Co-Marketing & Licence Agreement with US Dispense Vendor PDX

Jun 19, 2018 at 11:07 PM EDT · Issued by Adheris Health Limited

Filed with ASX · Jun 19, 2018 at 11:07 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/co-marketing-and-licence-agreement-with-us-dispense-vendor-pdx

Watch Adheris Health's latest callMedAdvisor Limited (MDR) Q1 2026 Earnings Call · Replay · Oct 21, 2025↗

Adheris Health Limited on 6ix

Earlier from Adheris Health

  • MDR Signs Agreement with EBOS Subsidiary ZESTJun 15, 2018
  • MedAdvisor to Launch Customised TerryWhite Chemmart AppMay 3, 2018
  • MDR March 2018 Quarterly Report & Appendix 4CApr 30, 2018
  • MDR H1 FY2018 Financial Report & Appendix 4DFeb 26, 2018
  • MDR December 2017 Quarterly Report & Appendix 4CJan 25, 2018

Later from Adheris Health

  • MedAdvisor and HPS Announce Integrated Medication SolutionAug 30, 2018
  • MedAdvisor FY18 Annual Report & Appendix 4EAug 31, 2018
  • MedAdvisor Expands Revenue Streams in Clinical TrialsSep 10, 2018
  • PEP and International UpdateNov 26, 2018
  • MedAdvisor to launch in Asia with Zuellig PharmaDec 2, 2018
All Adheris Health news releases↗

Follow Adheris Health into a list and get an email when it puts out news.

Follow Adheris Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer